Detalles de la búsqueda
1.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ann Hematol
; 102(7): 1773-1787, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171597
2.
Correction to: REMIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (polaBR), CART therapies, and lenalidomide/rituximab (R2) based on realworld data in patients with relapsed/refractory diffuse large Bcell lymphoma.
Ann Hematol
; 102(9): 2643-2644, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432417
3.
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.
Breast Cancer Res Treat
; 146(3): 573-82, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25007961
4.
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.
J Clin Oncol
; 41(35): 5363-5375, 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37689979
5.
Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer.
Clin Breast Cancer
; 15(4): 259-65, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25933934
6.
Prevalence and clinicopathologic correlates of O6-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs.
Clin Breast Cancer
; 14(4): 285-90, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24709436
7.
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.
Crit Rev Oncol Hematol
; 69(2): 175-82, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18774730
Resultados
1 -
7
de 7
1
Próxima >
>>